Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Kazia Therapeutics Limited (NASDAQ: KZIA)
KZIA Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-43.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
71.20%
KZIA Stock Analysis
KZIA
PE Ratio:
KZIA
PEG Ratio:
Not Available
KZIA
Forward EPS Growth (12 month):
0.00%
KZIA
PS Ratio:
14
KZIA
PSG Ratio:
-0.4
KZIA
Forward Revenue Growth (12 month):
-37.40%
KZIA Articles
No data was found